Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 6168196Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$1.2M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#11,651
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Philippe Andre Gallay as a PI. Multi-PI records show the full award amount for context.
- 1R01AI178605-01A1R01A NOVEL STRATEGY TO INHIBIT SARS-COV-2 INFECTION AND COVID-19$775.5Kaward amount
- 5R01AI143931-05R01Non-immunosuppressive Sanglifehrin Analogs as Therapeutic Agents for Viral Hepatitis-induced Liver Damage Development$452.5Kaward amount
Award organization
Organizations that administered FY2024 awards listing Philippe Andre Gallay as a PI.
FY2024 award administered by Scripps Research Institute (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardScripps Research Institute
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding